Intuitive Surgical Reports Strong Q1 Results Amid Analyst Price Target Adjustments
Intuitive Surgical (ISRG) reported better-than-expected first-quarter results with a significant increase in procedures and system placements. Barclays lowered its price target to $651 while maintaining an Overweight rating, whereas Baird raised its target to $610 but noted potential MedTech sentiment risks.
Tickers: $ISRG
Topics: ai stocks analyst ratings healthcare robotic surgery